Furthermore, α-synuclein knockdown using shRNAs proved to be neuroprotective in a PD rat model, reducing dopaminergic neuron loss and slowing the onset of motor impairments (Zharikov et al., 2015). The gene discussed is SNCA; the disease is Parkinson disease.